175 related articles for article (PubMed ID: 15611843)
1. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
[TBL] [Abstract][Full Text] [Related]
2. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
3. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
4. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling.
Bae S; Zhang L
J Pharmacol Exp Ther; 2005 Dec; 315(3):1125-35. PubMed ID: 16099927
[TBL] [Abstract][Full Text] [Related]
6. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
[TBL] [Abstract][Full Text] [Related]
7. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
8. Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts.
Li Y; Sato T
J Mol Cell Cardiol; 2001 Nov; 33(11):2047-53. PubMed ID: 11708848
[TBL] [Abstract][Full Text] [Related]
9. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
Bullard AJ; Govewalla P; Yellon DM
Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
[TBL] [Abstract][Full Text] [Related]
11. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.
Cai Z; Semenza GL
Circulation; 2004 May; 109(17):2050-3. PubMed ID: 15117842
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein.
Bhuiyan MS; Takada Y; Shioda N; Moriguchi S; Kasahara J; Fukunaga K
Cardiovasc Ther; 2008; 26(1):10-23. PubMed ID: 18466417
[TBL] [Abstract][Full Text] [Related]
17. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.
Shan X; Xu X; Cao B; Wang Y; Guo L; Zhu Q; Li J; Que L; Chen Q; Ha T; Li C; Li Y
Int J Cardiol; 2009 May; 134(3):384-92. PubMed ID: 18672303
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway.
Ueda K; Takano H; Hasegawa H; Niitsuma Y; Qin Y; Ohtsuka M; Komuro I
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):e108-13. PubMed ID: 16574892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
